Cargando…

Sphingosine-1-Phosphate-Triggered Expression of Cathelicidin LL-37 Promotes the Growth of Human Bladder Cancer Cells

It has been proven that tumour growth and progression are regulated by a variety of mediators released during the inflammatory process preceding the tumour appearance, but the role of inflammation in the development of bladder cancer is ambiguous. This study was designed around the hypothesis that s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wollny, Tomasz, Wnorowska, Urszula, Piktel, Ewelina, Suprewicz, Łukasz, Król, Grzegorz, Głuszek, Katarzyna, Góźdź, Stanisław, Kopczyński, Janusz, Bucki, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267432/ https://www.ncbi.nlm.nih.gov/pubmed/35806446 http://dx.doi.org/10.3390/ijms23137443

Ejemplares similares

The Role of Cathelicidin LL-37 in Cancer Development
por: Piktel, Ewelina, et al.
Publicado: (2015)

Candidacidal Activity of Selected Ceragenins and Human Cathelicidin LL-37 in Experimental Settings Mimicking Infection Sites
por: Durnaś, Bonita, et al.
Publicado: (2016)

Hypogelsolinemia and Decrease in Blood Plasma Sphingosine-1-Phosphate in Patients Diagnosed with Severe Acute Pancreatitis
por: Wollny, Tomasz, et al.
Publicado: (2021)

Anaerobic bacteria growth in the presence of cathelicidin LL-37 and selected ceragenins delivered as magnetic nanoparticles cargo
por: Durnaś, Bonita, et al.
Publicado: (2017)

Cathelicidin LL-37 in Health and Diseases of the Oral Cavity
por: Tokajuk, Joanna, et al.
Publicado: (2022)

Magnetic nanoparticles enhance the anticancer activity of cathelicidin LL-37 peptide against colon cancer cells
por: Niemirowicz, Katarzyna, et al.
Publicado: (2015)

Sphingosine-1-Phosphate Metabolism and Its Role in the Development of Inflammatory Bowel Disease
por: Wollny, Tomasz, et al.
Publicado: (2017)

Formulation and candidacidal activity of magnetic nanoparticles coated with cathelicidin LL-37 and ceragenin CSA-13
por: Niemirowicz, Katarzyna, et al.
Publicado: (2017)

Nanoantibiotics containing membrane-active human cathelicidin LL-37 or synthetic ceragenins attached to the surface of magnetic nanoparticles as novel and innovative therapeutic tools: current status and potential future applications
por: Wnorowska, Urszula, et al.
Publicado: (2020)

Ceragenin CSA-13 displays high antibacterial efficiency in a mouse model of urinary tract infection
por: Wnorowska, Urszula, et al.
Publicado: (2022)

Targeting the Gut Microbiota to Relieve the Symptoms of Irritable Bowel Syndrome
por: Wollny, Tomasz, et al.
Publicado: (2021)

Ceragenins and Ceragenin-Based Core-Shell Nanosystems as New Antibacterial Agents against Gram-Negative Rods Causing Nosocomial Infections
por: Karasiński, Maciej, et al.
Publicado: (2023)

Bacteria Residing at Root Canals Can Induce Cell Proliferation and Alter the Mechanical Properties of Gingival and Cancer Cells
por: Suprewicz, Łukasz, et al.
Publicado: (2020)

Core–shell magnetic nanoparticles display synergistic antibacterial effects against Pseudomonas aeruginosa and Staphylococcus aureus when combined with cathelicidin LL-37 or selected ceragenins
por: Niemirowicz, Katarzyna, et al.
Publicado: (2016)

Ceragenin CSA-13 as free molecules and attached to magnetic nanoparticle surfaces induce caspase-dependent apoptosis in human breast cancer cells via disruption of cell oxidative balance
por: Piktel, Ewelina, et al.
Publicado: (2018)

Pulmonary defense and the human cathelicidin hCAP-18/LL-37
por: Fahy, R. J., et al.
Publicado: (2005)

Efficacy of Cathelicidin LL-37 in an MRSA Wound Infection Mouse Model
por: Simonetti, Oriana, et al.
Publicado: (2021)

Biocompatible Materials in Otorhinolaryngology and Their Antibacterial Properties
por: Spałek, Jakub, et al.
Publicado: (2022)

Cathelicidin LL-37: An Antimicrobial Peptide with a Role in Inflammatory Skin Disease
por: Reinholz, Markus, et al.
Publicado: (2012)

Transformation of Human Cathelicidin LL-37 into Selective, Stable, and Potent Antimicrobial Compounds
por: Wang, Guangshun, et al.
Publicado: (2014)

Upregulation of human β-defensin-3 and cathelicidin LL-37 in Kaposi’s sarcoma
por: Fathy, Hanan, et al.
Publicado: (2012)

The Human Cathelicidin Antimicrobial Peptide LL-37 and Mimics are Potential Anticancer Drugs
por: Kuroda, Kengo, et al.
Publicado: (2015)

Human cathelicidin LL-37 enhance the antibiofilm effect of EGCG on Streptococcus mutans
por: Guo, Yi-jie, et al.
Publicado: (2016)

The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections
por: Babikir, Ibrahim H., et al.
Publicado: (2018)

Significance and Diagnostic Role of Antimicrobial Cathelicidins (LL-37) Peptides in Oral Health
por: Khurshid, Zohaib, et al.
Publicado: (2017)

Cathelicidin LL37 Promotes Osteogenic Differentiation in vitro and Bone Regeneration in vivo
por: Li, Lunhao, et al.
Publicado: (2021)

Hypogelsolinemia in Patients Diagnosed with Acute Myeloid Leukemia at Initial Stage of Sepsis
por: Wątek, Marzena, et al.
Publicado: (2019)

Mechanical Properties of the Extracellular Environment of Human Brain Cells Drive the Effectiveness of Drugs in Fighting Central Nervous System Cancers
por: Cieśluk, Mateusz, et al.
Publicado: (2022)

Bactericidal activities of the cationic steroid CSA-13 and the cathelicidin peptide LL-37 against Helicobacter pylori in simulated gastric juice
por: Leszczyńska, Katarzyna, et al.
Publicado: (2009)

Resveratrol Stimulates Sphingosine-1-Phosphate Signaling of Cathelicidin Production
por: Park, Kyungho, et al.
Publicado: (2013)

Use of ceragenins as a potential treatment for urinary tract infections
por: Wnorowska, Urszula, et al.
Publicado: (2019)

The Human Cathelicidin LL-37 Has Antiviral Activity against Respiratory Syncytial Virus
por: Currie, Silke M., et al.
Publicado: (2013)

Serum concentrations of antimicrobial peptide cathelicidin LL-37 in patients with bacterial lung infections
por: Majewski, Karol, et al.
Publicado: (2018)

Expression and function of cathelicidin hCAP18/LL-37 in chronic lymphocytic leukemia
por: Podaza, Enrique, et al.
Publicado: (2020)

Cathelicidin LL-37: A new important molecule in the pathophysiology of systemic lupus erythematosus
por: Moreno-Angarita, Alejandro, et al.
Publicado: (2019)

Secondary necrosis of apoptotic neutrophils induced by the human cathelicidin LL-37 is not proinflammatory to phagocytosing macrophages
por: Li, Hsin-Ni, et al.
Publicado: (2009)

The influence of cathelicidin LL37 in human anti-neutrophils cytoplasmic antibody (ANCA)-associated vasculitis
por: Zhang, Ying, et al.
Publicado: (2013)

The Human Cathelicidin Antimicrobial Peptide LL-37 as a Potential Treatment for Polymicrobial Infected Wounds
por: Duplantier, Allen J., et al.
Publicado: (2013)

Heparan Sulfate Proteoglycan–Involving Immunomodulation by Cathelicidin Antimicrobial Peptides LL-37 and PR-39
por: Kaneider, Nicole C., et al.
Publicado: (2007)

Cathelicidin LL-37 restoring glucocorticoid function in smoking and lipopolysaccharide-induced airway inflammation in rats
por: Weng, Jian-Zhen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_p9otl3aga8krb51lc49jdh7r45